News Conference News ACC 2023 STELLAR, ‘Impressive’ Results With Novel Drug Sotatercept in PAH Shelley Wood March 06, 2023
Presentation ACC 2023 The STELLAR Phase 3 Trial: A Study of Sotaterceptin Combination with Background Therapy for the Treatment of Pulmonary Arterial Hypertension Presenter: Marius M. Hoeper March 05, 2023
News Opinion Editor's Corner ACC 2023 What’s Going to Be Hot at ACC/WCC 2023? Shelley Wood February 27, 2023
News Conference News ACC 2022 CHAP: Better Blood Pressure Control, Better Pregnancy Outcomes Michael O'Riordan April 02, 2022
News Conference News ACC 2022 POISE-3: Tranexamic Acid Stems Bleeding During Noncardiac Surgery Todd Neale April 02, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Conference News ACC 2022 Can a Smartphone App Use Voice Patterns to Predict CAD Events? Caitlin E. Cox March 24, 2022
News Conference News ACC 2017 Does Hormone Replacement Therapy Curb Atherosclerosis? New Imaging Study Opens Old Questions Shelley Wood March 09, 2017
News Conference News ACC 2015 ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted Todd Neale March 20, 2015
News Conference News ACC 2015 Small Study Suggests Benefits of Denervation for Pulmonary Arterial Hypertension Todd Neale March 17, 2015
News Conference News ACC 2012 Study Looks at Long-term Mortality Predictors in TAVR Patients Jason Kahn March 27, 2012